Cambridge Investment Research Advisors, Inc. Ani Pharmaceuticals Inc Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$31.9 - $41.95 $169,867 - $223,383
5,325 New
5,325 $214,000
Q2 2019

Aug 15, 2019
SELL
$67.77 - $82.2 $203,310 - $246,600
-3,000 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$45.83 - $70.54 $137,490 - $211,620
3,000 New
3,000 $0

Others Institutions Holding ANIP

# of Institutions
212
Shares Held
18.8M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email